BrightView Health Youngstown

BrightView Health Youngstown

Services:
Type of Opioid Treatment
• Prescribes naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Federally-certified Opioid Treatment Program
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Buprenorphine maintenance
• Buprenorphine detoxification

Payment/Insurance/Funding Accepted

• Medicare
• Medicaid
• State-financed health insurance plan other than Medicaid
• Private health insurance
• Cash or self-payment
• Federal military insurance (e.g., TRICARE)

Treatment Approaches

• Motivational interviewing
• Trauma-related counseling
• Substance use disorder counseling
• Anger management
• Cognitive behavioral therapy
• Relapse prevention
• Telemedicine/telehealth therapy
• Contingency management/motivational incentives
• Matrix Model
• Brief intervention

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Facility Smoking Policy

• Smoking permitted in designated area

Age Groups Accepted

• Adults
• Young Adults

Recovery Support Services

• Housing services
• Employment counseling or training
• Assistance with obtaining social services
• Mentoring/peer support

Special Programs/Groups Offered

• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

Type of Care

• Detoxification
• Substance use treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Outpatient detoxification
• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Intensive outpatient treatment

Education and Counseling Services

• Substance use disorder education
• Family counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Marital/couples counseling
• HIV or AIDS education, counseling, or support
• Individual counseling
• Hepatitis education, counseling, or support
• Group counseling

Testing

• STD testing
• Testing for Hepatitis C (HCV)
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing
• HIV testing
• TB screening
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Facility Vaping Policy

• Vaping permitted in designated area

Gender Accepted

• Male
• Female

License/Certification/Accreditation

• State Substance use treatment agency
• Drug Enforcement Agency (DEA)
• SAMHSA certification for opioid treatment program (OTP)
• The Joint Commission

Pharmacotherapies

• Buprenorphine sub-dermal implant
• Naltrexone (extended-release, injectable)
• Buprenorphine without naloxone
• Lofexidine
• Naltrexone (oral)
• Buprenorphine (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Acamprosate (Campral®)
• Nicotine replacement
• Clonidine
• Buprenorphine with naloxone
• Disulfiram

Ancillary Services

• Transportation assistance
• Early intervention for HIV
• Case management service
• Social skills development

Detoxification (medical withdrawal) Services

• Opioids detoxification
• Methamphetamines detoxification
• Medication routinely used during detoxification
• Cocaine Detoxification
• Benzodiazepines Detoxification

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Assessment/Pre-treatment

• Screening for mental disorders
• Screening for tobacco use
• Comprehensive substance use assessment
• Screening for substance use
• Outreach to persons in the community
• Complete medical history/physical exam